Effect of curcumine (tumeric) on the inflammatory factors and lipid profile of patients with a history of acute coronary syndrome

Evaluation the effect of curcumine on the inflammatory factors and lipid profile of patients with a history of acute coronary syndrome

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20080901001165N39

Enrollment

Registered

2019-04-24

Start date

2018-12-31

Completion date

Unknown

Last updated

2019-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute coronary syndrome. ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction

Interventions

Intervention 1: Intervention group: pateints of the treatment group will recieve curcumin capsule (500 mg) every day after breakfast for 30 days. Intervention 2: Control group: pateints of the treatm

Eligibility

Sex/Gender

All

Age

12 Years to 75 Years

Inclusion criteria

Inclusion criteria: All patients with a history of acute coronary syndrome Under the age of 75 y/o

Exclusion criteria

Exclusion criteria: Age over 75 years Use of anticoagulants and warfarin Peptic ulcer History of bleeding, especially gastrointestinal bleeding Child bleeding History of major surgery or recent trauma Severe heart failure

Design outcomes

Primary

Measure	Time frame
Lipid profile changes. Timepoint: Baseline, 4 weeks after the start of the intervention. Method of measurement: Lab testing of lipid profile.	—

Secondary

Measure	Time frame
Decrease of inflammatory factors such as crp. Timepoint: Baseline, 4 weeks after the start of the intervention. Method of measurement: Lab testing of inflammatory factors such as CRP.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactYunes panahi

Bagheiat-allah University of Medical Sciences

Yunespanahi@bmsu.ac.ir+98 21 8248 2503

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026